Literature DB >> 10037562

Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities.

M F Marmor1, F Tan.   

Abstract

OBJECTIVES: To assess retinal function topographically in the posterior pole of affected and fellow eyes with central serous chorioretinopathy. PARTICIPANTS AND METHODS: Multifocal electroretinograms (MERGs) were recorded from 6 patient with active central serous chorioretinopathy and 5 normal control subjects. Two patients also had full-field conventional ERGs. The MERG responses were averaged in rings radiating out from the foveal center.
RESULTS: All of the patients had central macular detachments in the affected eyes, while the fellow eyes were normal except for a few small retinal pigment epithelial abnormalities. The MERG was not only depressed in areas of detachment as expected, but was also reduced beyond the area of detachment in affected eyes and throughout the posterior pole of the fellow eyes. Full-field ERGs were normal.
CONCLUSIONS: The MERG findings show that there is broad retinal functional disturbance in central serous chorioretinopathy involving both eyes and areas beyond the zone of detachment. These data strongly suggest that diffuse and possibly systemic pathologic conditions underlie this disease and that the leak itself may be a somewhat incidental event. The MERG may prove useful as a clinical marker for susceptibility to serous detachment.

Entities:  

Mesh:

Year:  1999        PMID: 10037562     DOI: 10.1001/archopht.117.2.184

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  22 in total

1.  Clinical applications of multifocal electroretinography.

Authors:  U Kretschmann; M Bock; R Gockeln; E Zrenner
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

2.  "Do you, doctor, take the mfERG.for better or for worse?".

Authors:  Michael F Marmor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-03-05       Impact factor: 3.117

3.  Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy.

Authors:  Pawan Gupta; Vishali Gupta; M R Dogra; Ramandeep Singh; Amod Gupta
Journal:  Int Ophthalmol       Date:  2009-01-30       Impact factor: 2.031

4.  Three-dimensional imaging by spectral domain optical coherence tomography in central serous chorioretinopathy with fibrin.

Authors:  Sandeep Saxena; Neha Sinha; Shashi Sharma
Journal:  J Ocul Biol Dis Infor       Date:  2012-05-22

Review 5.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

6.  Multifocal electroretinography in central serous chorio-retinopathy and assessment of the reproducibility of the multifocal electroretinography.

Authors:  Wei Zhang; Kangxing Zhao
Journal:  Doc Ophthalmol       Date:  2003-03       Impact factor: 2.379

7.  Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.

Authors:  H Imai; S Honda; Y Nakanishi; H Yamamoto; Y Tsukahara; A Negi
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

8.  First and second-order kernel multifocal electroretinography abnormalities in acute central serous chorioretinopathy.

Authors:  Timothy Y Y Lai; Ricky Y K Lai; Jasmine W S Ngai; Wai-Man Chan; Haitao Li; Dennis S C Lam
Journal:  Doc Ophthalmol       Date:  2007-08-29       Impact factor: 2.379

9.  Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.

Authors:  Scott C So; Thomas R Hedges; Joel S Schuman; Maria Luz Amaro Quireza
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2003 May-Jun

10.  Correlation between functional and anatomical assessments by multifocal electroretinography and optical coherence tomography in central serous chorioretinopathy.

Authors:  Yolanda W Y Yip; Jasmine W S Ngai; Andrew C T Fok; Ricky Y K Lai; Haitao Li; Dennis S C Lam; Timothy Y Y Lai
Journal:  Doc Ophthalmol       Date:  2010-04       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.